Access 2.8M+ Filings Sign Up Free
Xspray Pharma Logo

Xspray Pharma | XSPRAY - Profile, Filings, Stock Info & Investor Relations Data

Xspray Pharma | XSPRAY
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Sweden
Founded
2003
Xspray Pharma (XSPRAY)

Company Profile

Website
Investor Relations

About Xspray Pharma

Xspray Pharma AB (publ) is a pharmaceutical company with several product candidates in clinical development, the first XS004 dasatinib recently filed with the FDA. Xspray’s strategy is to improve the quality of life for cancer patients by launching improved PKI products with relevant medical benefits and cost effectiveness.

Xspray Pharma uses its innovative, patented RightSize™ technology to develop 505(b)(2) improved versions of marketed drugs, primarily protein kinase inhibitors (PKIs), for the treatment of cancer. The segment is the second largest in oncology and where drug prices are very high.

Xspray Pharma applies a unique platform technology:

- Improves the solubility of the active ingredient
- Best-in-class for high dose strength for poorly soluble drugs
- Fully amorphous (non-infringing to many crystalline products patents)

Market Presence

Worldwide

Headquarters

Scheeles väg 2
171 65, Solna
Sweden

Xspray Pharma (XSPRAY)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Xspray Pharma (XSPRAY)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Anders Ekblom (Other)
Buy SEK 4,998,000.00 SEK 29.75 10.01.25
↑
Ribbskottet AB Anders Bladh (Other)
Buy SEK 145,655.62 SEK 74.39 04.06.24
↑
Anders Bladh, Ribbskottet (Other)
Buy SEK 225,077.58 SEK 73.99 03.06.24
↑
Per Andersson (Other)
Buy SEK 489,545.54 SEK 9.46 29.05.24
↓
Per Andersson (Other)
Sell SEK 687,545.00 SEK 69.10 27.05.24
↑
Anders Bladh (Other)
Buy SEK 503,500.00 SEK 50.35 16.05.24
◆
Maris Hartmanis (Other)
Other SEK 95,400.00 SEK 40.00 02.05.24
◆
Christine Lind (Other)
Other SEK 26,640.00 SEK 40.00 02.05.24
◆
Anders Ekblom (Other)
Other SEK 20,000.00 SEK 40.00 02.05.24
↑
Robert Molander (Other)
Buy USD 20,000.00 USD 4.00 05.03.24

Xspray Pharma (XSPRAY)
Stock & Investor Information

ISINs

SE0009973563
SE0018042517
SE0023312756
SE0023312764

LEI

549300NGRQCNZ3X4L157

Stock Exchange Listings

Nasdaq Stockholm

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals